Virtus ETF Advisers LLC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 81 filers reported holding DESIGN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$43,219
-65.9%
18,313
-9.1%
0.03%
-65.3%
Q2 2023$126,863
+92.9%
20,137
+76.7%
0.08%
+108.3%
Q1 2023$65,755
-59.4%
11,396
-27.8%
0.04%
-57.6%
Q4 2022$161,841
+24.5%
15,774
+102.9%
0.08%
+63.5%
Q3 2022$130,000
+20.4%
7,775
+0.8%
0.05%
+30.0%
Q2 2022$108,0007,7160.04%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders